335 related articles for article (PubMed ID: 8773809)
1. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
O'Brien JT; Ames D; Schweitzer I; Colman P; Desmond P; Tress B
Br J Psychiatry; 1996 Jun; 168(6):679-87. PubMed ID: 8773809
[TBL] [Abstract][Full Text] [Related]
2. The function of the hypothalamic-pituitary-adrenal axis in Alzheimer's disease. Response to insulin hypoglycaemia.
O'Brien JT; Schweitzer I; Ames D; Mastwyk M; Colman P
Br J Psychiatry; 1994 Nov; 165(5):650-7. PubMed ID: 7866680
[TBL] [Abstract][Full Text] [Related]
3. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.
Elgh E; Lindqvist Astot A; Fagerlund M; Eriksson S; Olsson T; Näsman B
Biol Psychiatry; 2006 Jan; 59(2):155-61. PubMed ID: 16125145
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings.
Swanwick GR; Kirby M; Bruce I; Buggy F; Coen RF; Coakley D; Lawlor BA
Am J Psychiatry; 1998 Feb; 155(2):286-9. PubMed ID: 9464214
[TBL] [Abstract][Full Text] [Related]
5. HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
[TBL] [Abstract][Full Text] [Related]
6. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
Acta Psychiatr Scand; 1990 Apr; 81(4):364-71. PubMed ID: 2343764
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease.
Swanwick GR; Coen RF; Walsh JB; Coakley D; Lawlor BA
Biol Psychiatry; 1996 Jun; 39(11):976-8. PubMed ID: 9162211
[No Abstract] [Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
Nelson WH; Orr WW; Stevenson JM; Shane SR
Arch Gen Psychiatry; 1982 Sep; 39(9):1033-6. PubMed ID: 7115012
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of hypothalamic-pituitary-adrenal axis function in depressed alcoholic patients.
Targum SD; Wheadon DE; Chastek CT; McCabe WJ; Advani MT
J Affect Disord; 1982 Dec; 4(4):347-53. PubMed ID: 6219148
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
Kathol RG; Jaeckle RS; Lopez JF; Meller WH
Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
[TBL] [Abstract][Full Text] [Related]
11. The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines.
Molchan SE; Hill JL; Mellow AM; Lawlor BA; Martinez R; Sunderland T
Int Psychogeriatr; 1990; 2(2):99-122. PubMed ID: 1713799
[TBL] [Abstract][Full Text] [Related]
12. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
[TBL] [Abstract][Full Text] [Related]
13. Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease.
O'Brien JT; Ames D; Schweitzer I; Mastwyk M; Colman P
Psychol Med; 1996 Jan; 26(1):7-14. PubMed ID: 8643765
[TBL] [Abstract][Full Text] [Related]
14. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
Zis AP; Haskett RF; Albala AA; Carroll BJ; Lohr NE
Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
[TBL] [Abstract][Full Text] [Related]
15. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
Molchan SE; Hill JL; Martinez RA; Lawlor BA; Mellow AM; Rubinow DR; Bissette G; Nemeroff CB; Sunderland T
Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
[TBL] [Abstract][Full Text] [Related]
16. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
Stewart JW; Quitkin FM; McGrath PJ; Klein DF
J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
[TBL] [Abstract][Full Text] [Related]
17. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
[TBL] [Abstract][Full Text] [Related]
18. Noradrenergic function and the cortisol response to dexamethasone in depression.
Rubin AL; Price LH; Charney DS; Heninger GR
Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
[TBL] [Abstract][Full Text] [Related]
19. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients.
Roy M; Collier B; Roy A
Psychiatry Res; 1990 Jan; 31(1):31-7. PubMed ID: 2156275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
